ℹ️
🇬🇧
Search
Search for people relevant for "Determination"
Determination
Person
Class
Person
Publication
Programmes
Export current view
doc. MUDr. Jakub Radocha Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
6 classes
122 publications
Classes
class
Internal Medicine I
+1
FDP033 |
Faculty of Medicine in Hradec Králové
class
Internal Medicine II
+1
FDP034 |
Faculty of Medicine in Hradec Králové
class
Internal Medicine III
+1
FDP048 |
Faculty of Medicine in Hradec Králové
Publications
publication
Importance of FLC determination in patients with MGUS and in complete remission of multiple myeloma
2012 |
Faculty of Medicine in Hradec Králové
publication
Abnormal hyperbilirubinemia in a patient with multiple myeloma
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
Isotype class switching after transplantation in multiple myeloma
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Isotype class switching after transplantation in multiple myeloma
2007 |
Publication without faculty affiliation
publication
Investigation of primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia
2006 |
Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
Investigation of primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia
2006 |
Faculty of Medicine in Hradec Králové
publication
Investigation of primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia
2006 |
Publication without faculty affiliation
publication
The role of intracellular zinc in modulation of life and death of Hep-2 cells
+1
2003 |
Central Library of Charles University
publication
Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
publication
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
2023 |
Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
Load more publications (112)
Loading network view...